Moonlake Immunotherapeutics (MLTX) PT Lowered to $66 at Jefferies
Tweet
Share
E-mailGet Alerts MLTX Hot Sheet
Price: $12.12 -6.05%
Rating Summary:
12 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
12 Buy, 4 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Jefferies analyst Kelly Shi lowered the price target on Moonlake Immunotherapeutics (NASDAQ: MLTX) to $66.00 (from $79.00) while maintaining a Buy rating.
You May Also Be Interested In
- Okta, Inc (OKTA) PT Raised to $235 at DA Davidson Following Oktane 2026
- Tsuruha Holdings Inc (3391:JP) (TSUSF) PT Lowered to JPY2,240 at UBS
- On Holding AG (ONON) PT Raised to $33 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
